Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-07-02
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
STV Analysis Versus Visual Evaluation of Cardiotocography in FGR
NCT06010238
Early Lung Function Trajectories: Comparison Between Infants With and Without Intrauterine Growth Restriction.
NCT06919757
USCOM Parameters in Preterm Infants: Reference Ranges
NCT05961657
Doppler Ultrasound Compared With Stethoscope to Assess Heart Rate (HR)
NCT04242654
Evaluation of Gastric Residuals and Feedings Progression
NCT04064398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fetal Growth Restriction diagnosed > 27w6d gestation
Patients with a new diagnosis of fetal growth restriction after 27 weeks 6 days' gestation.
USCOM
Device that measures how much blood is being pumped in and out of the heart.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
USCOM
Device that measures how much blood is being pumped in and out of the heart.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Fetal anomalies
* Gestational diabetes or pregestational diabetes.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rachel Meislin
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicola F Tavella, MPH
Role: STUDY_DIRECTOR
Icahn School of Medicine at Mount Sinai
Rachel J Meislin, MD
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Sinai Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-23-01681
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.